NASH Observatory

⏿ The PanNASH Initiative is an interactive web-based platform presenting global NASH statistics to inform NASH control and research.

International NASH Day 2023: Empowering Healthcare Professionals

International NASH Day
On International NASH Day 2023, PanNASH amplifies the importance of NASH awareness, education, and action. Learn about the complex multisystem nature of NASH, the potential of PPAR agonists in NASH management, and the role of healthcare professionals in delivering effective, patient-centered care. Discover how PanNASH resources are empowering the medical community and join us in taking action against NASH.
Read MoreInternational NASH Day 2023: Empowering Healthcare Professionals

Hepatocellular carcinoma surveillance in NAFLD patients

Authors: Cholankeril G, El-Serag H.
Published in Seminars in liver disease 2022
Nonalcoholic fatty liver disease (NAFLD) is characterised by the presence of hepatic steatosis without significant alcohol consumption or concomitant liver disease. Patients with NAFLD-related cirrhosis are at a high risk of developing liver complications, including hepatocellular carcinoma (HCC).
Read MoreHepatocellular carcinoma surveillance in NAFLD patients

Coffee achieves its beneficial effects through modulation of insulin resistance in a NAFLD mouse model

Authors: Kakiyama G, Minowa K, Rodriguez-Agudo D et al.
Published in American Journal of Physiology, Gastrointestinal and Liver Physiology 2022
Coffee achieves its beneficial effects through modulation of insulin resistance in a NAFLD mouse model
Read MoreCoffee achieves its beneficial effects through modulation of insulin resistance in a NAFLD mouse model

SUBSCRIBE & FOLLOW US

SUBSCRIBE TO OUR MONTHLY NEWSLETTER TO GET THE LATEST UPDATES